2.Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proceedings of the National Academy of Sciences. 2009
3.Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling. Proceedings of the National Academy of Sciences. 2014
4.Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer. Breast Cancer Research. 2015
5.A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer. Science Translational Medicine. 2021
- 卫生室|《乡村医生诊疗口袋书(先行本)》面世
- 鲁南制药集团|菏泽医学专科学校“鲁南制药产业学院”揭牌
- 收发|一图读懂 | 科学收取快递 做好健康防护
- 解读|《浙江省医院门诊管理办法》政策解读
- 方面|“四九”第一天，科学养生，健康过冬
- 廉东波|《健谈》观点丨浅表性胃炎三五年复查一次 萎缩性胃炎一年一查
- 家长|杭州《青少年皮肤健康状况调研》发布，近半青少年受皮肤疾病困扰
- 李大可|八成女性都有可能感染HPV！科学预防很关键
- 疫苗|戴口罩真的很重要！流调人员：佩戴口罩不科学，风险等级则从严判断
- 公报,监测,国民,体质|一图读懂《第五次国民体质监测公报》